Establishment of a central laboratory serum tumor marker service on a consolidated immunodiagnostic platform: development of practice standards, service improvements, and operational efficiency.
D000046:Academic Medical Centers; D000951:Antigens, Neoplasm / Q000097:blood* / Q000276:immunology; D014408:Biomarkers, Tumor / Q000097:blood* / Q000191:economics / Q000276:immunology; D017598:Efficiency, Organizational; D017721:Hospital Costs; D006801:Humans; D007202:Indicators and Reagents / Q000191:economics; D007755:Laboratories, Hospital / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data*; D008404:Massachusetts; D009369:Neoplasms / Q000175:diagnosis*; D010338:Pathology, Clinical / Q000191:economics / Q000379:methods / Q000592:standards; D011785:Quality Assurance, Health Care; D012189:Retrospective Studies; D014600:Utilization Review
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D007202:Indicators and Reagents